IBRX - Why ImmunityBio Stock Is Trading Higher Thursday | Benzinga
ImmunityBio, Inc. (NASDAQ:IBRX) shares are moving higher Thursday after the company announced insurance coverage of ANKTIVA across multiple states.
The Details: ANKTIVA is a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments.
The immunotherapy received FDA approval less than two months ...